Moneycontrol PRO

you are here: HomeNewsBusinessMarketsAurobindo may see 4% EPS dilution in near term: CIMB

SHOW NAMES

Trending Topics

business

Aurobindo may see 4% EPS dilution in near term: CIMB

According to Prakash Agarwal of CIMB, the Aurobindo Pharma-Actavis deal seems lucrative on the medium-to-long-term perspective.

first published: Jan 21, 2014 03:17 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Live: Nifty slips below 25,200, LG Electronics shares down after blockbuster debut | Closing Bell
Why markets haven’t delivered and why they will turn now
Nifty Upmove Hinges On Quarterly Earnings; Will LG Electronics See A Listing Pop?|Opening Bell Live
Live: Nifty snaps 2-day winning streak but rebounds from day's low | Closing Bell | 4K

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347